Sort
51,593 grants matching “hepatitis”
CLINICAL IMPACT ON HCV &ALCOHOL IN HIV INFECTED PERSONS
$799,516Boston Medical Center · R01 · FY2001 · AA
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
$799,353Louise Sumner · Gryphon Scientific, Llc · N01 · FY2024 · AI
RISK FACTORS FOR AIDS AMONG IV DRUG USERS
$799,335Beth Israel Medical Ctr (New York) · R01 · FY2002 · DA
Prospective Investigation of Cirrhotic Cardiomyopathy in Humans
$799,287Manhal Jaber Izzy · Vanderbilt University Medical Center · R01 · FY2025 · HL
Retroviral infection and new modulators of the MHCII pathway
$799,185Tatyana V. Golovkina · University Of Chicago · R01 · FY2024 · AI
Cardiovascular risk from comprehensive evaluation of the CT calcium score exam
$799,168David L Wilson · Case Western Reserve University · R01 · FY2023 · HL
A systems immunology approach for predicting poor responses to Hepatitis B vaccination
$799,004Ramin Herati · New York University School Of Medicine · R01 · FY2025 · AI
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$798,964Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2009 · CA
Agonists of the RIG-I Innate Immune Pathway
$798,935Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2013 · AI
Risk Stratification for and Early Detection of Liver Cancer
$798,777Fasiha Kanwal · Baylor College Of Medicine · U01 · FY2025 · CA
The Pharmacology of Dermal Fibrosis
$798,312Bruce Neil Cronstein · New York University School Of Medicine · R01 · FY2009 · AR
Neurodegeneration and Brain Function in Aging with HIV and Parkinson's Disease
$798,305Tilman Schulte · Sri International · R01 · FY2016 · AA
Inflammation-mediated Insulin Resistance and Oncogenesis
$798,209Michel Bernier · National Institute On Aging · Z01 · FY2008 · AG
Predictors, consequences and mechanisms of accelerated lung aging in HIV
$797,845Gregory D Kirk · Johns Hopkins University · R01 · FY2015 · HL
T cell Immunity and the Outcome of Acute HCV Infection
$797,768Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2016 · AI
Mechanisms for regulation of a novel class of anti-diabetic lipids
$797,742Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2021 · DK
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$797,698James L. Sorensen · University Of California, San Francisco · UG1 · FY2019 · DA
Organogenesis of Ectopic Tissue in Lymph Node
$797,697Eric Lagasse · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · DK
Ribosome Heterogeneity as a Mechanism for Metabolic Regulation
$797,665Jean E Schaffer · Joslin Diabetes Center · DP1 · FY2022 · DK
Hepatitis C: Studies of Immunity and Pathogenesis
$797,618Charles M. Rice · Rockefeller University · U19 · FY2008 · AI
Molecular Biology of Picornavirus Replication
$797,403Elvera Ehrenfeld · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Monkey Alcohol Tissue Research Resource (MATRR)
$797,394Kathleen A Grant · Oregon Health & Science University · R24 · FY2011 · AA
PATHOGENESIS OF HEPATITIS B VIRUS IN TRANSGENIC MICE
$797,386Scripps Research Institute · R01 · FY2004 · CA
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$797,362Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2018 · AI
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD
$797,316Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2017 · DK